Literature DB >> 17434634

Association between serum resistin and carotid intima media thickness in hypertension patients.

Hyun-Joon Shin1, Sungha Park, Se-Jung Yoon, Dae Shik Choi, Deok-Kyu Cho, Jung-Sun Kim, Young-Guk Ko, Donghoon Choi, Yangsoo Jang, Namsik Chung.   

Abstract

BACKGROUND: Resistin is an adipocytokine belonging to the family of cysteine rich secretory proteins. We sought to determine if a correlation between resistin levels and carotid atherosclerosis exists in hypertensive patients.
METHODS: This study consisted of 307 treated hypertensive patients. Subjects were grouped into tertiles according to their resistin level.
RESULTS: Carotid intima media thickness (IMT) was significantly highest in the third tertile. The first tertile had a mean carotid IMT and a mean of maximum carotid IMT of 0.63+/-0.08 and 0.81+/-0.10 mm, respectively. The 2nd tertile had measurements of 0.63+/-0.08 and 0.81+/-0.12 mm, and the 3rd tertile 0.67+/-0.12 and 0.86+/-0.11 for the same parameters. (p=0.002). Resistin levels were independently associated with the carotid IMT (mean carotid IMT: R(2)=0.159, p<0.001 and mean of maximum carotid IMT: R(2)=0.162, p<0.001) after controlling for age, gender, HDL cholesterol, triglyceride, LDL cholesterol, smoking and DM. The tertile level of resistin was significantly associated with (odds ratio=3.097, p=0.004) risk of coronary artery disease after controlling for age, gender, HDL cholesterol, triglyceride, LDL cholesterol, smoking, DM and carotid IMT.
CONCLUSION: Serum resistin is independently associated with increasing carotid IMT in treated hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17434634     DOI: 10.1016/j.ijcard.2007.02.028

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

1.  Local perivascular adiponectin associates with lower extremity vascular operative wound complications.

Authors:  Gaurav Sharma; Rohan Kulkarni; Samir K Shah; William W King; Alban Longchamp; Ming Tao; Kui Ding; C Keith Ozaki
Journal:  Surgery       Date:  2016-04-14       Impact factor: 3.982

2.  Perivascular adipose adiponectin correlates with symptom status of patients undergoing carotid endarterectomy.

Authors:  Gaurav Sharma; Ming Tao; Kui Ding; David Yu; William King; Galina Deyneko; Xiaosong Wang; Alban Longchamp; Frederick J Schoen; C Keith Ozaki; Marcus E Semel
Journal:  Stroke       Date:  2015-05-12       Impact factor: 7.914

3.  Resistin, but not adiponectin and leptin, is associated with the risk of ischemic stroke among postmenopausal women: results from the Women's Health Initiative.

Authors:  Swapnil N Rajpathak; Robert C Kaplan; Sylvia Wassertheil-Smoller; Mary Cushman; Thomas E Rohan; Aileen P McGinn; Tao Wang; Howard D Strickler; Philipp E Scherer; Rachel Mackey; David Curb; Gloria Y F Ho
Journal:  Stroke       Date:  2011-05-05       Impact factor: 7.914

4.  Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis.

Authors:  C P Chung; A G Long; J F Solus; Y H Rho; A Oeser; P Raggi; C Michael Stein
Journal:  Lupus       Date:  2009-08       Impact factor: 2.911

5.  Resistin might not be a risk factor for carotid artery atherosclerosis in elderly Chinese males.

Authors:  Hao Wang; Yu-Tang Wang; Li Fan; Yu-Tao Guo; Yang Shi; Tao Tao; Yue-Xiang Zhao
Journal:  J Geriatr Cardiol       Date:  2014-09       Impact factor: 3.327

6.  Resistin derived from diabetic perivascular adipose tissue up-regulates vascular expression of osteopontin via the AP-1 signalling pathway.

Authors:  So Youn Park; Kyu Hee Kim; Kyo Won Seo; Jin Ung Bae; Yun Hak Kim; Seung Jin Lee; Won Suk Lee; Chi Dae Kim
Journal:  J Pathol       Date:  2014-01       Impact factor: 7.996

7.  Is there a relationship between resistin levels and left ventricular end-diastolic pressure?

Authors:  Özge Turgay Yıldırım; Aylin Yıldırır; Leyla Elif Sade; Senem Has Hasırcı; Hatice Kozan; Emre Özçalık; Kaan Okyay; Uğur Abbas Bal; Alp Aydınalp; Haldun Müderrisoğlu
Journal:  Anatol J Cardiol       Date:  2018-04       Impact factor: 1.596

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.